Status:
RECRUITING
Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
Lead Sponsor:
Stanford University
Conditions:
Aneuploidy
Mosaicism
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk...
Detailed Description
Genetic testing modality and results will be recorded Pregnancy per transfer will be recorded Patients in the study agree to provide medical records of their pregnancy. Any genetic testing or fetal...
Eligibility Criteria
Inclusion
- Available aneuploid or mosaic embryos
- No other acceptable embryos available
- Willing to travel to Stanford for treatment
- English language fluency
Exclusion
- Use of international donor eggs or sperm not tested according to FDA guidelines.
- Living outside the United States
- Embryos with Triploidy are not eligible for transfer in this protocol
Key Trial Info
Start Date :
April 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2039
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04109846
Start Date
April 11 2019
End Date
April 1 2039
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Fertility and Reproductive Medicine Center
Sunnyvale, California, United States, 94087